Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes

NCT02143440 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02143440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2012
Completion date
May 31, 2014
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes.